{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:49:31Z","timestamp":1740134971964,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["817347"],"award-info":[{"award-number":["817347"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0716-4","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T09:48:08Z","timestamp":1543225688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Xing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hainan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meirong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-4477","authenticated-orcid":false,"given":"Houbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"716_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317\u201320.","journal-title":"Science"},{"key":"716_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.10807","volume":"55","author":"SD Wait","year":"2004","unstructured":"Wait SD, Vortmeyer AO, Lonser RR, Chang DT, Finn MA, Bhowmick DA, et al. Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Ann Neurol. 2004;55:236\u201340.","journal-title":"Ann Neurol"},{"key":"716_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.iae.0000244659.62202.ee","volume":"27","author":"CC Chan","year":"2007","unstructured":"Chan CC, Collins AB, Chew EY. Molecular pathology of eyes with von Hippel-Lindau (VHL) disease: a review. Retina. 2007;27:1\u20137.","journal-title":"Retina"},{"key":"716_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","volume":"46","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields CL, von Shields JA. Hippel-Lindau disease. Surv Ophthalmol. 2001;46:117\u201342.","journal-title":"Surv Ophthalmol"},{"key":"716_CR5","first-page":"495","volume":"103","author":"EY Chew","year":"2005","unstructured":"Chew EY. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc. 2005;103:495\u2013511.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"716_CR6","first-page":"3067","volume":"43","author":"H Dollfus","year":"2002","unstructured":"Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, et al. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci. 2002;43:3067\u201374.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"716_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063832","volume":"8","author":"XF Huang","year":"2013","unstructured":"Huang XF, Xiang P, Chen J, Xing DJ, Huang N, Min Q, et al. Targeted exome sequencing identified novel USH2A mutations in usher syndrome families. PLoS One. 2013;8:e63832.","journal-title":"PLoS One"},{"key":"716_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0065-230X(01)82003-0","volume":"82","author":"SC Clifford","year":"2001","unstructured":"Clifford SC, Maher ER. Von Hippel-Lindau disease: clinical and molecular perspectives. Adv Cancer Res. 2001;82:85\u2013105.","journal-title":"Adv Cancer Res"},{"key":"716_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/jhg.2012.10","volume":"57","author":"P Wu","year":"2012","unstructured":"Wu P, Zhang N, Wang X, Ning X, Li T, Bu D, et al. Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J Hum Genet. 2012;57:238\u201343.","journal-title":"J Hum Genet"},{"key":"716_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179551417705122","volume":"10","author":"C Sriphrapradang","year":"2017","unstructured":"Sriphrapradang C, Choopun K, Tunteeratum A, Sura T. Genotype-phenotype correlation in patients with germline mutations of VHL, RET, SDHB, and SDHD genes: Thai experience. Clin Med Insights Endocrinol Diabetes. 2017;10:1\u20137.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"716_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2002;2:673\u201382.","journal-title":"Nat Rev Cancer"},{"key":"716_CR12","doi-asserted-by":"publisher","first-page":"H2528","DOI":"10.1152\/ajpheart.01077.2005","volume":"290","author":"K Schultz","year":"2006","unstructured":"Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2006;290:H2528\u201334.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"716_CR13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","volume":"109","author":"LP Aiello","year":"2002","unstructured":"Aiello LP, George DJ, Cahill MT, Wong JS, Cavallerano J, Hannah AL, et al. Rapid and durable recovery of visual function in a patient with von hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416. Ophthalmology. 2002;109:1745\u201351.","journal-title":"Ophthalmology"},{"key":"716_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","volume":"136","author":"JF Girmens","year":"2003","unstructured":"Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol. 2003;136:194\u20136.","journal-title":"Am J Ophthalmol"},{"key":"716_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1874364101004010066","volume":"4","author":"FN Hrisomalos","year":"2010","unstructured":"Hrisomalos FN, Maturi RK, Pata V. Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-Lindau associated retinal hemangioblastomas. Open Ophthalmol J. 2010;4:66\u20139.","journal-title":"Open Ophthalmol J"},{"key":"716_CR16","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min JH, Yang H, Ivan M, Gertler F, Kaelin WG, Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science. 2002;296:1886\u20139.","journal-title":"Science"},{"key":"716_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000;2:423\u20137.","journal-title":"Nat Cell Biol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0716-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:15:33Z","timestamp":1574709333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0716-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0716-4","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board and the Ethics Committee of Chinese PLA General Hospital. Informed written consent comprised DNA extraction, gene analysis and ophthalmological examinations. 150 normal controls were used in the study. Written informed consent was obtained from all participants, while the consent of the 6-year-old and 12-year-old patients was signed by their father.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients to publish their cases in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"204"}}